Nicotine clinical trials at UCSF
5 in progress, 1 open to eligible people
Nicotine is a chemical in tobacco that can lead to addiction. UCSF is running studies on electronic cigarette use and its effects on the body. They focus on use behaviors, chemical exposure, and biological changes.
Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
open to eligible people ages 21-70
This is a crossover study that will examine use behaviors, chemical exposures, and biological effects of Standardized Research Electronic Cigarette (SREC) compared to usual brand e-cigarette use in natural or synthetic nicotine users.
San Francisco, California
Exposure of Healthy Nonsmokers to Secondhand and Thirdhand Cigarette Smoke
Sorry, currently not accepting new patients, but might later
This study compares the health effects of dermal and inhalational exposure to thirdhand cigarette smoke to those of inhalational exposure to secondhand cigarette smoke in healthy, adult nonsmokers. Our hypothesis is that dermal exposure increases exposure to the tobacco specific carcinogen, NNK and may affect both endothelial function and epidermal integrity.
San Francisco, California
Pharmacodynamics of Synthetic Nicotine
Sorry, not yet accepting patients
In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.
San Francisco, California
Melanin and Dermal Uptake of Thirdhand Cigarette Smoke
Sorry, not yet accepting patients
This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.
San Francisco, California
Clinical Pharmacology of Marijuana-Tobacco Co-administration
Sorry, not yet accepting patients
This is a crossover, randomized, double-blinded clinical pharmacology study enrolling dual cannabis-tobacco smokers to better understand the combined effects of co-administering cannabis and tobacco. The project aims to describe the pharmacokinetics and pharmacodynamics of marijuana-tobacco co-administration by delivering THC and nicotine in various combinations. This foundational study will establish a research program focused on elucidating the public health consequences of marijuana-tobacco co-use.
San Francisco, California
Our lead scientists for Nicotine research studies include Suzaynn Schick Neal Benowitz, MD.
Last updated: